Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Enliven Therapeutics, Inc. (ELVN)
USD50.87
-0.22 (-0.43%)
US NASDAQ Healthcare Biotechnology
Address
6200 Lookout Road 80301
Boulder, CO, US
Boulder, CO, US
CEO
Richard A. Fair
Website
enliventherapeutics.com
IPO
2020-03-12
CIK 1672619 ISIN US29337E1029
Description
Enliven Therapeutics, Inc. is a biopharmaceutical enterprise, currently in the clinical development phase, dedicated to discovering and advancing small molecule therapeutic agents aimed at combating cancer. Its pipeline includes ELVN-001, a small molecule kinase inhibitor currently in a Phase 1 clinical trial for adult patients with chronic myeloid leukemia. Another key candidate, ELVN-002, also a small molecule kinase inhibitor, has begun a Phase 1 clinical assessment for individuals with cancers exhibiting an abnormal HER2 gene. The company's base of operations is located in Boulder, Colorado.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD50.87
-0.22 (-0.43%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
0.40
Float Shares
34.83M
Free Float %
57.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +6.85% | +2.94% | -6.66% | +55.74% | +108.37% | +174.68% | +122.51% | +118.04% | +34.89% | -29.50% | -29.50% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Buy
Price Targets & DCF
Current price
50.87
Low
59.00
+16.0%
Consensus
69.50
+36.6%
Median
69.50
+36.6%
High
80.00
+57.3%
DCF (Unlevered)
1.70
-96.7%
DCF (Levered)
1.74
-96.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 8 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
59.00
+16.0%
|
| Last Quarter | 1 |
59.00
+16.0%
|
| Last Year | 2 |
55.50
+9.1%
|
| All Time | 7 |
42.14
-17.2%
|
Quality scores
Altman Z-Score
125.21
Safe zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
2 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+3.2% Q1'26: +33.3% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%— Q1'26: -8,790.8% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+20.4% Q1'26: +25.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 3 EPS Ana. |
Dec 2027 3 Rev. Ana. 2 EPS Ana. |
Dec 2028 3 Rev. Ana. 5 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
|
—
est: 10.0K (-100.0%)
|
10.0K
10.0K – 10.0K
+0.0% YoY
|
10.0K
10.0K – 10.0K
+0.0% YoY
|
16.7K
16.7K – 16.7K
+66.7% YoY
|
69.50M
69.50M – 69.50M
+416,861.7% YoY
|
333.08M
333.08M – 333.08M
+379.3% YoY
|
| EBITDA |
-104.24M
|
-119.40M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-104.55M
|
-119.66M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-89.02M
est: -91.85M (+3.1%)
|
-103.69M
est: -98.78M (-5.0%)
|
-113.09M
-116.70M – -81.69M
-14.5% YoY
|
-134.92M
-134.92M – -134.92M
-19.3% YoY
|
-161.43M
-209.48M – -113.38M
-19.6% YoY
|
-179.06M
-179.06M – -179.06M
-10.9% YoY
|
-48.10M
-48.10M – -48.10M
+73.1% YoY
|
| SGA |
23.78M
|
33.80M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-1.89
est: -1.95 (+2.9%)
|
-1.83
est: -1.74 (-5.5%)
|
-1.75
-2.06 – -1.44
-0.9% YoY
|
-2.38
-2.38 – -2.38
-36.0% YoY
|
-3.04
-3.70 – -2.00
-27.5% YoY
|
-3.16
-3.16 – -3.16
-4.1% YoY
|
-0.85
-0.85 – -0.85
+73.1% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-08 | Goldman Sachs | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-06 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-05 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-04 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-01 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-30 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-29 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-28 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-27 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-15 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
37
Total invested
146.97M
Insider transactions (90d)
1
Beneficial owners (>5%)
3
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) BlackRock, Inc. | 2.94M | 6.20% | 2.90M | — | 2.94M | — | HC | Delaware | 2024-11-08 | ↗ |
| 2 | Polar Capital Holdings Plc | 2.69M | 5.69% | 2.69M | — | 2.69M | — | HC | United Kingdom | 2024-11-13 | ↗ |
| 3 | Polar Capital LLP | 2.69M | 5.69% | 2.69M | — | 2.69M | — | IA | United Kingdom | 2024-11-13 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
37
-90 vs prev Q
New positions
10
Closed positions
98
Increased
28
Reduced
5
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 199.3K +199.3K (+100.0%) | 3.07B +3.1B (+100.0%) | 0.32% +0.321 pp | 0.76% +0.758 pp | USD15.40 +0.0% | 1 qtrs NEW |
| 2 | ORBIMED ADVISORS LLC | 7.96M +— (+0.0%) | 122.58M -40.4M (-24.8%) | 12.82% +0.000 pp | 2.51% -1.328 pp | USD21.90 -29.7% | 12 qtrs — |
| 3 | FMR LLC | 7.11M -21.6K (-0.3%) | 109.46M -36.5M (-25.0%) | 11.45% -0.035 pp | 0.01% -0.002 pp | USD19.97 -22.9% | 12 qtrs — |
| 4 | COMMODORE CAPITAL LP | 4.69M +— (+0.0%) | 72.27M -23.8M (-24.8%) | 7.56% +0.000 pp | 4.81% +0.121 pp | USD19.93 -22.7% | 12 qtrs — |
| 5 | VESTAL POINT CAPITAL, LP | 3.83M +2.7M (+230.2%) | 58.98M +35.2M (+148.4%) | 6.17% +4.300 pp | 2.01% +0.933 pp | USD16.91 -8.9% | 3 qtrs — |
| 6 | FAIRMOUNT FUNDS MANAGEMENT LLC | 3.71M +— (+0.0%) | 57.16M -18.8M (-24.8%) | 5.98% +0.000 pp | 4.35% -2.485 pp | USD20.69 -25.6% | 12 qtrs — |
| 7 | BLACKROCK, INC. | 3.61M +94.8K (+2.7%) | 55.65M -16.4M (-22.7%) | 5.82% +0.153 pp | 0.00% 0.000 pp | USD24.42 -36.9% | 6 qtrs — |
| 8 | POLAR CAPITAL HOLDINGS PLC | 3.51M +418.7K (+13.5%) | 54.11M -9.2M (-14.6%) | 5.66% +0.674 pp | 0.21% -0.096 pp | USD21.19 -27.3% | 7 qtrs — |
| 9 | VR ADVISER, LLC | 3.23M +— (+0.0%) | 49.69M -16.4M (-24.8%) | 5.20% +0.000 pp | 2.45% -1.263 pp | USD19.61 -21.5% | 12 qtrs — |
| 10 | VANGUARD GROUP INC | 2.80M +248.7K (+9.7%) | 43.15M -9.1M (-17.4%) | 4.51% +0.400 pp | 0.00% 0.000 pp | USD20.53 -25.0% | 12 qtrs — |
| 11 | JANUS HENDERSON GROUP PLC | 1.67M -121.9K (-6.8%) | 25.74M -11.0M (-29.8%) | 2.69% -0.196 pp | 0.01% -0.005 pp | USD21.03 -26.8% | 12 qtrs — |
| 12 | POINT72 ASSET MANAGEMENT, L.P. | 1.50M +464.2K (+44.6%) | 23.17M +1.9M (+8.8%) | 2.42% +0.748 pp | 0.03% -0.010 pp | USD18.60 -17.2% | 4 qtrs — |
| 13 | NOVO HOLDINGS A/S | 1.48M +53.7K (+3.8%) | 22.79M -6.4M (-21.9%) | 2.38% +0.087 pp | 1.77% -0.112 pp | USD19.99 -23.0% | 3 qtrs — |
| 14 | CITADEL ADVISORS LLC | 1.42M +263.8K (+22.7%) | 21.93M -1.8M (-7.7%) | 2.29% +0.425 pp | 0.00% 0.000 pp | USD20.14 -23.5% | 12 qtrs — |
| 15 | CAPITAL RESEARCH GLOBAL INVESTORS | 1.30M -11.1K (-0.8%) | 20.09M -6.8M (-25.4%) | 2.10% -0.018 pp | 0.00% -0.001 pp | USD20.06 -23.2% | 3 qtrs — |
| 16 | PICTET ASSET MANAGEMENT HOLDING SA | 1.30M -94.9K (-6.8%) | 20.07M -8.5M (-29.9%) | 2.10% -0.153 pp | 0.02% -0.008 pp | USD22.11 -30.3% | 7 qtrs — |
| 17 | STATE STREET CORP | 1.05M +87.7K (+9.1%) | 16.21M -3.5M (-17.9%) | 1.70% +0.141 pp | 0.00% 0.000 pp | USD20.58 -25.2% | 12 qtrs — |
| 18 | GEODE CAPITAL MANAGEMENT, LLC | 1.05M -36.3K (-3.3%) | 16.15M -6.1M (-27.3%) | 1.69% -0.058 pp | 0.00% 0.000 pp | USD20.87 -26.2% | 12 qtrs — |
| 19 | SOLEUS CAPITAL MANAGEMENT, L.P. | 1.03M +1.0M (+100.0%) | 15.79M +15.8M (+100.0%) | 1.65% +1.651 pp | 0.58% +0.582 pp | USD15.40 +0.0% | 1 qtrs NEW |
| 20 | BLACKSTONE INC. | 954.9K -365.6K (-27.7%) | 14.71M -12.3M (-45.6%) | 1.54% -0.589 pp | 0.06% -0.051 pp | USD20.73 -25.7% | 8 qtrs — |
| 21 | ROCK SPRINGS CAPITAL MANAGEMENT LP | 798.4K +112.3K (+16.4%) | 12.30M -1.7M (-12.5%) | 1.29% +0.181 pp | 0.63% -0.190 pp | USD18.78 -18.0% | 8 qtrs — |
| 22 | 5AM VENTURE MANAGEMENT, LLC | 772.5K +— (+0.0%) | 11.90M -3.9M (-24.8%) | 1.24% +0.000 pp | 3.74% -2.052 pp | USD21.90 -29.7% | 12 qtrs — |
| 23 | CANDRIAM S.C.A. | 453.0K -156.3K (-25.7%) | 6.98M -5.5M (-44.1%) | 0.73% -0.252 pp | 0.03% -0.031 pp | USD20.19 -23.7% | 3 qtrs — |
| 24 | MORGAN STANLEY | 411.8K +153.4K (+59.4%) | 6.34M +1.1M (+19.9%) | 0.66% +0.247 pp | 0.00% +0.000 pp | USD18.59 -17.2% | 12 qtrs — |
| 25 | DIMENSIONAL FUND ADVISORS LP | 398.9K +238.4K (+148.6%) | 6.14M +2.9M (+87.1%) | 0.64% +0.384 pp | 0.00% +0.001 pp | USD17.39 -11.4% | 3 qtrs — |
| 26 | MARSHALL WACE, LLP | 371.9K +31.4K (+9.2%) | 5.73M -1.2M (-17.8%) | 0.60% +0.051 pp | 0.01% -0.002 pp | USD19.75 -22.0% | 7 qtrs — |
| 27 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 355.2K -8.0K (-2.2%) | 5.47M -2.0M (-26.4%) | 0.57% -0.013 pp | 0.00% 0.000 pp | USD19.43 -20.7% | 11 qtrs — |
| 28 | NORTHERN TRUST CORP | 352.2K -42.2K (-10.7%) | 5.42M -2.6M (-32.8%) | 0.57% -0.068 pp | 0.00% 0.000 pp | USD21.08 -26.9% | 11 qtrs — |
| 29 | LOGOS GLOBAL MANAGEMENT LP | 340.0K +— (+0.0%) | 5.24M -1.7M (-24.8%) | 0.55% +0.000 pp | 0.32% -0.307 pp | USD19.72 -21.9% | 12 qtrs — |
| 30 | PATIENT SQUARE CAPITAL LP | 308.1K +57.3K (+22.8%) | 4.75M -389.3K (-7.6%) | 0.50% +0.092 pp | 1.02% -0.358 pp | USD21.75 -29.2% | 6 qtrs — |
| 31 | WOODLINE PARTNERS LP | 301.0K +524.0 (+0.2%) | 4.64M -1.5M (-24.6%) | 0.48% +0.001 pp | 0.02% -0.011 pp | USD18.95 -18.7% | 10 qtrs — |
| 32 | MILLENNIUM MANAGEMENT LLC | 296.9K -84.5K (-22.1%) | 4.57M -3.2M (-41.4%) | 0.48% -0.136 pp | 0.00% -0.001 pp | USD20.57 -25.1% | 6 qtrs — |
| 33 | BAKER BROS. ADVISORS LP | 271.4K +156.6K (+136.3%) | 4.18M +1.8M (+77.8%) | 0.44% +0.252 pp | 0.02% +0.008 pp | USD16.88 -8.8% | 8 qtrs — |
| 34 | GOLDMAN SACHS GROUP INC | 237.2K -25.1K (-9.6%) | 3.65M -1.7M (-32.0%) | 0.38% -0.040 pp | 0.00% 0.000 pp | USD21.64 -28.8% | 12 qtrs — |
| 35 | SPHERA FUNDS MANAGEMENT LTD. | 226.8K +60.0K (+36.0%) | 3.49M +78.5K (+2.3%) | 0.37% +0.097 pp | 0.68% -0.045 pp | USD18.71 -17.7% | 4 qtrs — |
| 36 | EXOME ASSET MANAGEMENT LLC | 222.3K +222.3K (+100.0%) | 3.42M +3.4M (+100.0%) | 0.36% +0.358 pp | 1.64% +1.637 pp | USD15.40 +0.0% | 1 qtrs NEW |
| 37 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 194.7K +160.0K (+459.9%) | 3.00M +2.3M (+321.2%) | 0.31% +0.258 pp | 0.01% +0.006 pp | USD16.31 -5.6% | 2 qtrs — |
| 38 | AVIDITY PARTNERS MANAGEMENT LP | 140.3K +— (+0.0%) | 2.16M -711.3K (-24.8%) | 0.23% +0.000 pp | 0.62% -0.030 pp | USD20.41 -24.5% | 4 qtrs — |
| 39 | WELLINGTON MANAGEMENT GROUP LLP | 129.9K +21.3K (+19.6%) | 2.00M -222.1K (-10.0%) | 0.21% +0.034 pp | 0.00% +0.000 pp | USD21.75 -29.2% | 7 qtrs — |
| 40 | BANK OF NEW YORK MELLON CORP | 110.6K -5.0K (-4.4%) | 1.70M -663.9K (-28.1%) | 0.18% -0.008 pp | 0.00% 0.000 pp | USD21.11 -27.0% | 12 qtrs — |
| 41 | NUVEEN, LLC | 105.4K -2.8K (-2.6%) | 1.62M -591.9K (-26.7%) | 0.17% -0.005 pp | 0.00% 0.000 pp | USD19.82 -22.3% | 4 qtrs — |
| 42 | JANE STREET GROUP, LLC | 102.0K +102.0K (+100.0%) | 1.57M +1.6M (+100.0%) | 0.16% +0.164 pp | 0.00% +0.000 pp | USD15.40 +0.0% | 12 qtrs — |
| 43 | HIGHVISTA STRATEGIES LLC | 82.5K -176.6K (-68.1%) | 1.27M -4.0M (-76.0%) | 0.13% -0.284 pp | 0.33% -0.973 pp | USD20.06 -23.2% | 11 qtrs — |
| 44 | BARCLAYS PLC | 69.9K +13.7K (+24.3%) | 1.08M -359.7K (-25.1%) | 0.11% +0.005 pp | 0.00% 0.000 pp | USD20.84 -26.1% | 12 qtrs — |
| 45 | LIGHTHOUSE INVESTMENT PARTNERS, LLC | 65.0K +65.0K (+100.0%) | 1.00M +1.0M (+100.0%) | 0.10% +0.105 pp | 0.03% +0.030 pp | USD15.40 +0.0% | 1 qtrs NEW |
| 46 | SWISS NATIONAL BANK | 64.3K +1.1K (+1.7%) | 989.8K -303.3K (-23.5%) | 0.10% +0.002 pp | 0.00% 0.000 pp | USD20.38 -24.4% | 11 qtrs — |
| 47 | XTX TOPCO LTD | 60.7K +60.7K (+100.0%) | 934.8K +934.8K (+100.0%) | 0.10% +0.098 pp | 0.02% +0.025 pp | USD15.40 +0.0% | 4 qtrs — |
| 48 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 60.4K +12.3K (+25.5%) | 930.4K -54.9K (-5.6%) | 0.10% +0.020 pp | 0.01% -0.003 pp | USD19.44 -20.8% | 5 qtrs — |
| 49 | UBS GROUP AG | 57.9K -21.6K (-27.2%) | 891.2K -736.4K (-45.2%) | 0.09% -0.035 pp | 0.00% 0.000 pp | USD21.01 -26.7% | 12 qtrs — |
| 50 | UBS ASSET MANAGEMENT AMERICAS INC | 55.2K +3.5K (+6.8%) | 850.2K -207.7K (-19.6%) | 0.09% +0.006 pp | 0.00% +0.000 pp | USD20.88 -26.2% | 7 qtrs — |
| 51 | PRELUDE CAPITAL MANAGEMENT, LLC | 52.6K +52.6K (+100.0%) | 809.7K +809.7K (+100.0%) | 0.08% +0.085 pp | 0.06% +0.060 pp | USD15.40 +0.0% | 1 qtrs NEW |
| 52 | RHUMBLINE ADVISERS | 50.5K -9.7K (-16.0%) | 777.8K -453.6K (-36.8%) | 0.08% -0.016 pp | 0.00% 0.000 pp | USD20.50 -24.9% | 11 qtrs — |
| 53 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 48.7K +17.0K (+53.6%) | 750.6K +100.9K (+15.5%) | 0.08% +0.027 pp | 0.01% +0.001 pp | USD18.43 -16.4% | 3 qtrs — |
| 54 | AMERICAN CENTURY COMPANIES INC | 45.8K +34.3K (+297.9%) | 705.2K +469.6K (+199.3%) | 0.07% +0.055 pp | 0.00% +0.000 pp | USD16.67 -7.6% | 2 qtrs — |
| 55 | JUMP FINANCIAL, LLC | 45.4K +45.4K (+100.0%) | 698.5K +698.5K (+100.0%) | 0.07% +0.073 pp | 0.01% +0.009 pp | USD15.40 +0.0% | 1 qtrs NEW |
| 56 | WELLS FARGO & COMPANY/MN | 43.1K +17.2K (+66.7%) | 663.1K +134.4K (+25.4%) | 0.07% +0.028 pp | 0.00% +0.000 pp | USD18.58 -17.1% | 12 qtrs — |
| 57 | ALLIANCEBERNSTEIN L.P. | 36.8K +— (+0.0%) | 567.3K -186.8K (-24.8%) | 0.06% +0.000 pp | 0.00% 0.000 pp | USD18.92 -18.6% | 10 qtrs — |
| 58 | PRUDENTIAL FINANCIAL INC | 35.6K +35.6K (+100.0%) | 547.9K +547.9K (+100.0%) | 0.06% +0.057 pp | 0.00% +0.001 pp | USD15.40 +0.0% | 1 qtrs NEW |
| 59 | BANK OF AMERICA CORP /DE/ | 32.7K +9.2K (+38.9%) | 503.7K +21.8K (+4.5%) | 0.05% +0.008 pp | 0.00% +0.000 pp | USD19.83 -22.3% | 12 qtrs — |
| 60 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 32.2K +11.9K (+58.4%) | 496.0K +79.7K (+19.1%) | 0.05% +0.019 pp | 0.00% +0.000 pp | USD18.71 -17.7% | 11 qtrs — |
| 61 | DEUTSCHE BANK AG\ | 31.4K +6.2K (+24.7%) | 483.9K -31.8K (-6.2%) | 0.05% +0.010 pp | 0.00% +0.000 pp | USD20.49 -24.8% | 11 qtrs — |
| 62 | ADAR1 CAPITAL MANAGEMENT, LLC | 30.0K +30.0K (+100.0%) | 462.0K +462.0K (+100.0%) | 0.05% +0.048 pp | 0.03% +0.034 pp | USD15.40 +0.0% | 1 qtrs NEW |
| 63 | TUDOR INVESTMENT CORP ET AL | 29.7K +13.4K (+82.0%) | 457.0K +123.2K (+36.9%) | 0.05% +0.017 pp | 0.00% +0.000 pp | USD18.19 -15.3% | 4 qtrs — |
| 64 | AQUATIC CAPITAL MANAGEMENT LLC | 28.0K +28.0K (+100.0%) | 430.5K +430.5K (+100.0%) | 0.05% +0.045 pp | 0.01% +0.012 pp | USD15.40 +0.0% | 1 qtrs NEW |
| 65 | LEGAL & GENERAL GROUP PLC | 27.1K -6.7K (-19.9%) | 416.7K -274.5K (-39.7%) | 0.04% -0.011 pp | 0.00% 0.000 pp | USD20.01 -23.0% | 11 qtrs — |
| 66 | INVESCO LTD. | 24.7K +1.6K (+7.0%) | 380.7K -92.1K (-19.5%) | 0.04% +0.003 pp | 0.00% +0.000 pp | USD16.75 -8.1% | 10 qtrs — |
| 67 | METLIFE INVESTMENT MANAGEMENT, LLC | 24.6K +— (+0.0%) | 378.2K -124.5K (-24.8%) | 0.04% +0.000 pp | 0.00% -0.001 pp | USD21.26 -27.6% | 11 qtrs — |
| 68 | PRICE T ROWE ASSOCIATES INC /MD/ | 23.8K -207.5K (-89.7%) | 367.0K -4.4M (-92.3%) | 0.04% -0.334 pp | 0.00% -0.001 pp | USD20.13 -23.5% | 7 qtrs — |
| 69 | SQUAREPOINT OPS LLC | 20.8K -15.1K (-42.1%) | 319.8K -414.0K (-56.4%) | 0.03% -0.024 pp | 0.00% 0.000 pp | USD20.47 -24.8% | 2 qtrs — |
| 70 | JPMORGAN CHASE & CO | 20.7K -4.1K (-16.6%) | 318.8K -189.2K (-37.2%) | 0.03% -0.014 pp | 0.00% +0.000 pp | USD20.56 -25.1% | 12 qtrs — |
| 71 | STATE OF WISCONSIN INVESTMENT BOARD | 20.4K -27.3K (-57.2%) | 314.1K -661.7K (-67.8%) | 0.03% -0.044 pp | 0.00% -0.002 pp | USD20.85 -26.1% | 11 qtrs — |
| 72 | FRANKLIN RESOURCES INC | 20.2K -410.1K (-95.3%) | 310.6K -8.5M (-96.5%) | 0.03% -0.660 pp | 0.00% -0.002 pp | USD20.32 -24.2% | 6 qtrs — |
| 73 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 19.3K -24.7K (-56.1%) | 297.8K -603.0K (-66.9%) | 0.03% -0.040 pp | 0.00% -0.001 pp | USD21.00 -26.7% | 9 qtrs — |
| 74 | AMERIPRISE FINANCIAL INC | 18.9K -104.4K (-84.6%) | 291.8K -2.2M (-88.4%) | 0.03% -0.168 pp | 0.00% -0.001 pp | USD20.74 -25.7% | 5 qtrs — |
| 75 | CITIGROUP INC | 18.5K +6.7K (+57.4%) | 284.7K +44.3K (+18.4%) | 0.03% +0.011 pp | 0.00% +0.000 pp | USD20.24 -23.9% | 12 qtrs — |
| 76 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 18.3K -1.2K (-6.4%) | 281.6K -118.1K (-29.6%) | 0.03% -0.002 pp | 0.00% 0.000 pp | USD23.20 -33.6% | 7 qtrs — |
| 77 | INTECH INVESTMENT MANAGEMENT LLC | 16.7K +2.3K (+15.6%) | 257.6K -38.6K (-13.0%) | 0.03% +0.004 pp | 0.00% 0.000 pp | USD21.08 -26.9% | 5 qtrs — |
| 78 | VIRTUS INVESTMENT ADVISERS, INC. | 15.8K +10.0K (+172.6%) | 243.0K +124.5K (+105.1%) | 0.03% +0.016 pp | 0.07% +0.032 pp | USD17.02 -9.5% | 4 qtrs — |
| 79 | AXQ CAPITAL, LP | 14.2K +14.2K (+100.0%) | 219.4K +219.4K (+100.0%) | 0.02% +0.023 pp | 0.05% +0.050 pp | USD15.40 +0.0% | 1 qtrs NEW |
| 80 | SG AMERICAS SECURITIES, LLC | 14.0K -8.2K (-36.9%) | 216.0K -239.0K (-52.5%) | 0.02% -0.013 pp | 0.00% -0.001 pp | USD21.60 -28.7% | 10 qtrs — |
| 81 | FOX RUN MANAGEMENT, L.L.C. | 12.4K +12.4K (+100.0%) | 191.5K +191.5K (+100.0%) | 0.02% +0.020 pp | 0.03% +0.030 pp | USD15.40 +0.0% | 1 qtrs NEW |
| 82 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 11.2K +123.0 (+1.1%) | 171.9K -54.1K (-23.9%) | 0.02% +0.000 pp | 0.00% 0.000 pp | USD21.61 -28.7% | 5 qtrs — |
| 83 | CANADA PENSION PLAN INVESTMENT BOARD | 10.8K +10.8K (+100.0%) | 166.3K +166.3K (+100.0%) | 0.02% +0.017 pp | 0.00% +0.000 pp | USD15.40 +0.0% | 1 qtrs NEW |
| 84 | STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 10.5K +— (+0.0%) | 161.4K -53.1K (-24.8%) | 0.02% +0.000 pp | 0.00% 0.000 pp | USD22.70 -32.2% | 7 qtrs — |
| 85 | QUEST PARTNERS LLC | 10.3K +5.6K (+119.9%) | 159.2K +63.0K (+65.4%) | 0.02% +0.009 pp | 0.01% +0.003 pp | USD17.71 -13.0% | 8 qtrs — |
| 86 | LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 10.3K +— (+0.0%) | 158.6K -52.2K (-24.8%) | 0.02% +0.000 pp | 0.01% -0.003 pp | USD20.47 -24.8% | 2 qtrs — |
| 87 | PROFUND ADVISORS LLC | 10.2K +10.2K (+100.0%) | 156.8K +156.8K (+100.0%) | 0.02% +0.016 pp | 0.00% +0.005 pp | USD15.40 +0.0% | 1 qtrs NEW |
| 88 | BNP PARIBAS ARBITRAGE, SNC | 9.7K +528.0 (+5.8%) | 148.9K -38.2K (-20.4%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD20.74 -25.7% | 5 qtrs — |
| 89 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 9.7K -712.0 (-6.9%) | 148.9K -63.6K (-29.9%) | 0.02% -0.001 pp | 0.01% -0.006 pp | USD20.03 -23.1% | 9 qtrs — |
| 90 | NEW YORK STATE COMMON RETIREMENT FUND | 9.1K -6.0K (-39.7%) | 140.1K -168.9K (-54.7%) | 0.01% -0.010 pp | 0.00% 0.000 pp | USD21.66 -28.9% | 11 qtrs — |
| 91 | LOS ANGELES CAPITAL MANAGEMENT LLC | 5.4K +5.4K (+100.0%) | 129.7K +129.7K (+100.0%) | 0.01% +0.009 pp | 0.00% +0.000 pp | USD15.40 +0.0% | 1 qtrs NEW |
| 92 | KLP KAPITALFORVALTNING AS | 6.8K +— (+0.0%) | 104.7K -34.5K (-24.8%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD21.60 -28.7% | 5 qtrs — |
| 93 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 6.2K +6.2K (+100.0%) | 94.9K +94.9K (+100.0%) | 0.01% +0.010 pp | 0.00% +0.000 pp | USD15.40 +0.0% | 1 qtrs NEW |
| 94 | AMERITAS INVESTMENT PARTNERS, INC. | 3.4K +— (+0.0%) | 53.1K -17.5K (-24.8%) | 0.01% +0.000 pp | 0.00% -0.001 pp | USD21.42 -28.1% | 11 qtrs — |
| 95 | RUSSELL INVESTMENTS GROUP, LTD. | 3.1K -521.0 (-14.3%) | 48.1K -26.5K (-35.5%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD19.68 -21.7% | 9 qtrs — |
| 96 | MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 2.9K +594.0 (+25.9%) | 44.4K -2.5K (-5.3%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD20.93 -26.4% | 11 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.85
Neutral
Ratio by volume
1.90
Bullish
Buys
22
Sells
26
Shares acquired
935.4K
Shares disposed
492.2K
Cash buys
—
Cash sales
21.00
Net activity
+443,176
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-17 | Collins Helen Louise | Officer | M-Exempt | D | Stock Option (right to buy) | 5,000 | 2.48 | 12.4K | 131,268 | D | ↗ |
| 2026-03-25 | Collins Helen Louise | Officer | M-Exempt | D | Stock Option (right to buy) | 40,000 | 2.48 | 99.2K | 136,268 | D | ↗ |
| 2026-03-17 | Collins Helen Louise | Officer | M-Exempt | D | Stock Option (right to buy) | 5,000 | 2.48 | 12.4K | 176,268 | D | ↗ |
| 2026-03-10 | Collins Helen Louise | Officer | M-Exempt | D | Stock Option (right to buy) | 10,129 | 2.48 | 25.1K | 181,268 | D | ↗ |
| 2026-03-09 | Collins Helen Louise | Officer | M-Exempt | A | Common Stock | 29,871 | 2.48 | 74.1K | 54,871 | D | ↗ |
| 2026-03-06 | Hohl Benjamin | Officer | S-Sale | D | Common Stock | 10,000 | 29.58 | 295.8K | 51,000 | D | ↗ |
| 2026-02-17 | Heyman Richard A. | Director | S-Sale | D | Common Stock | 1,230 | 26.18 | 32.2K | 22,647 | I | ↗ |
| 2026-02-17 | Collins Helen Louise | Officer | M-Exempt | D | Stock Option (right to buy) | 45,000 | 2.48 | 111.6K | 221,268 | D | ↗ |
| 2026-02-12 | Patel Anish | Officer | A-Award | A | Stock Option (right to buy) | 120,000 | 27.16 | 3.26M | 120,000 | D | ↗ |
| 2026-02-12 | Lyssikatos Joseph P | Officer | A-Award | A | Common Stock | 18,750 | 0.00 | — | 18,750 | D | ↗ |
| 2026-02-12 | Kunkel Lori Anne | Director | A-Award | A | Stock Option (right to buy) | 17,126 | 27.16 | 465.1K | 17,126 | D | ↗ |
| 2026-02-12 | Hohl Benjamin | Officer | A-Award | A | Common Stock | 25,000 | 0.00 | — | 61,000 | D | ↗ |
| 2026-02-12 | Heyman Richard A. | Director | A-Award | A | Stock Option (right to buy) | 19,234 | 27.16 | 522.4K | 19,234 | D | ↗ |
| 2026-02-12 | Gupta Rishi | Director | A-Award | A | Stock Option (right to buy) | 1,580 | 27.16 | 42.9K | 1,580 | D | ↗ |
| 2026-02-12 | Garland J. Scott | Director | A-Award | A | Stock Option (right to buy) | 1,427 | 27.16 | 38.8K | 1,427 | D | ↗ |
| 2026-02-12 | Derynck Mika K | Director | A-Award | A | Stock Option (right to buy) | 17,126 | 27.16 | 465.1K | 17,126 | D | ↗ |
| 2026-02-12 | Collins Helen Louise | Officer | A-Award | A | Common Stock | 25,000 | 0.00 | — | 25,000 | D | ↗ |
| 2026-02-12 | Bauer Jake | Director | A-Award | A | Stock Option (right to buy) | 17,126 | 27.16 | 465.1K | 17,126 | D | ↗ |
| 2026-02-12 | Ballal Rahul D. | Director | A-Award | A | Stock Option (right to buy) | 17,126 | 27.16 | 465.1K | 17,126 | D | ↗ |
| 2026-02-06 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 5,000 | 29.04 | 145.2K | 740,188 | I | ↗ |
| 2026-01-20 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 14,509 | 26.90 | 390.3K | 745,188 | I | ↗ |
| 2026-01-20 | Heyman Richard A. | Director | S-Sale | D | Common Stock | 718 | 26.96 | 19.4K | 23,877 | I | ↗ |
| 2026-01-09 | Patel Anish | Officer | S-Sale | D | Common Stock | 48,057 | 27.98 | 1.34M | 215,254 | I | ↗ |
| 2026-01-09 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 41,198 | 24.90 | 1.03M | 815,188 | I | ↗ |
| 2026-01-09 | Heyman Richard A. | Director | S-Sale | D | Common Stock | 4,285 | 25.00 | 107.1K | 25,107 | I | ↗ |
| 2026-01-08 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 7,500 | 20.13 | 151.0K | 890,188 | I | ↗ |
| 2026-01-08 | Heyman Richard A. | Director | S-Sale | D | Common Stock | 8,015 | 25.04 | 200.7K | 29,392 | I | ↗ |
| 2026-01-07 | Garland J. Scott | Director | — | — | Stock Option (right to buy) | 13,508 | 22.47 | 303.5K | 0 | D | ↗ |
| 2025-12-22 | Hohl Benjamin | Officer | M-Exempt | D | Stock Option (right to buy) | 13,000 | 2.48 | 32.2K | 92,056 | D | ↗ |
| 2025-12-19 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 5,000 | 16.84 | 84.2K | 897,688 | I | ↗ |
| 2025-12-17 | Kunkel Lori Anne | Director | M-Exempt | A | Common Stock | 15,958 | 1.12 | 17.9K | 30,712 | D | ↗ |
| 2025-12-11 | Fair Richard A. | Director / Officer | A-Award | A | Stock Option (right to buy) | 875,000 | 18.77 | 16.42M | 875,000 | D | ↗ |
| 2025-12-08 | Patel Anish | Officer | S-Sale | D | Common Stock | 4,958 | 20.76 | 102.9K | 265,016 | I | ↗ |
| 2025-11-19 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 12,008 | 22.30 | 267.8K | 903,180 | I | ↗ |
| 2025-11-17 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 12,500 | 21.82 | 272.7K | 890,392 | I | ↗ |
| 2025-11-07 | Patel Anish | Officer | S-Sale | D | Common Stock | 613 | 17.94 | 11.0K | 269,974 | I | ↗ |
| 2025-10-20 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 12,500 | 22.08 | 276.0K | 915,188 | I | ↗ |
| 2025-10-17 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 12,500 | 21.33 | 266.7K | 902,892 | I | ↗ |
| 2025-10-07 | Patel Anish | Officer | S-Sale | D | Common Stock | 6,667 | 20.10 | 134.0K | 276,641 | I | ↗ |
| 2025-09-29 | Hohl Benjamin | Officer | M-Exempt | D | Stock Option (right to buy) | 3,250 | 2.48 | 8.1K | 105,056 | D | ↗ |
| 2025-09-26 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 4,000 | 20.25 | 81.0K | 927,688 | I | ↗ |
| 2025-09-26 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 3,700 | 20.06 | 74.2K | 915,392 | I | ↗ |
| 2025-09-23 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 1,500 | 20.03 | 30.0K | 931,688 | I | ↗ |
| 2025-09-23 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 2,800 | 20.03 | 56.1K | 919,092 | I | ↗ |
| 2025-09-19 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 4,870 | 19.11 | 93.1K | 935,318 | I | ↗ |
| 2025-09-19 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 1,000 | 20.25 | 20.3K | 921,892 | I | ↗ |
| 2025-09-17 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 5,000 | 19.09 | 95.5K | 922,892 | I | ↗ |
| 2025-09-08 | Patel Anish | Officer | S-Sale | D | Common Stock | 6,667 | 20.24 | 135.0K | 283,308 | I | ↗ |
| 2025-08-27 | Hohl Benjamin | Officer | M-Exempt | D | Stock Option (right to buy) | 3,250 | 2.48 | 8.1K | 108,306 | D | ↗ |
| 2025-08-21 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 7,500 | 20.01 | 150.1K | 940,188 | I | ↗ |
| 2025-08-20 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 1,517 | 20.00 | 30.3K | 927,892 | I | ↗ |
| 2025-08-19 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 5,000 | 19.62 | 98.1K | 947,688 | I | ↗ |
| 2025-08-19 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 590 | 20.00 | 11.8K | 929,409 | I | ↗ |
| 2025-08-18 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 10,393 | 20.02 | 208.1K | 929,999 | I | ↗ |
| 2025-08-07 | Patel Anish | Officer | S-Sale | D | Common Stock | 6,262 | 18.20 | 113.9K | 290,380 | I | ↗ |
| 2025-07-28 | Hohl Benjamin | Officer | M-Exempt | A | Common Stock | 3,250 | 2.48 | 8.1K | 26,250 | D | ↗ |
| 2025-07-21 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 11,924 | 22.26 | 265.5K | 953,264 | I | ↗ |
| 2025-07-17 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 4,150 | 21.58 | 89.6K | 948,742 | I | ↗ |
| 2025-07-10 | Hohl Benjamin | Officer | M-Exempt | D | Stock Option (right to buy) | 1,000 | 2.48 | 2.5K | 114,806 | D | ↗ |
| 2025-07-07 | Patel Anish | Officer | S-Sale | D | Common Stock | 305 | 20.69 | 6.3K | 296,642 | I | ↗ |
| 2025-06-27 | Hohl Benjamin | Officer | S-Sale | D | Common Stock | 3,052 | 20.86 | 63.7K | 23,198 | D | ↗ |
| 2025-06-20 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 12,500 | 21.40 | 267.5K | 965,188 | I | ↗ |
| 2025-06-17 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 10,502 | 22.08 | 231.8K | 954,890 | I | ↗ |
| 2025-06-13 | Hohl Benjamin | Officer | M-Exempt | D | Stock Option (right to buy) | 3,000 | 2.48 | 7.4K | 119,056 | D | ↗ |
| 2025-06-09 | Patel Anish | Officer | S-Sale | D | Common Stock | 6,607 | 20.33 | 134.3K | 303,369 | I | ↗ |
| 2025-06-03 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 7,500 | 20.03 | 150.2K | 977,688 | I | ↗ |
| 2025-06-03 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 7,500 | 20.05 | 150.4K | 965,392 | I | ↗ |
| 2025-05-27 | Hohl Benjamin | Officer | M-Exempt | A | Common Stock | 3,250 | 2.48 | 8.1K | 26,250 | D | ↗ |
| 2025-05-19 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 5,000 | 16.31 | 81.5K | 985,188 | I | ↗ |
| 2025-05-19 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 5,000 | 16.49 | 82.5K | 972,892 | I | ↗ |
| 2025-05-07 | Patel Anish | Officer | S-Sale | D | Common Stock | 6,173 | 18.30 | 112.9K | 310,470 | I | ↗ |
| 2025-05-02 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 2,470 | 20.01 | 49.4K | 990,188 | I | ↗ |
| 2025-05-02 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 2,170 | 20.00 | 43.4K | 977,892 | I | ↗ |
| 2025-05-01 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 5,030 | 20.07 | 101.0K | 992,658 | I | ↗ |
| 2025-05-01 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 5,330 | 20.08 | 107.0K | 980,062 | I | ↗ |
| 2025-04-28 | Hohl Benjamin | Officer | M-Exempt | A | Common Stock | 3,250 | 2.48 | 8.1K | 26,250 | D | ↗ |
| 2025-04-21 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 4,670 | 16.03 | 74.8K | 998,018 | I | ↗ |
| 2025-04-17 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 5,000 | 16.42 | 82.1K | 985,392 | I | ↗ |
| 2025-04-07 | Patel Anish | Officer | S-Sale | D | Common Stock | 3,756 | 17.81 | 66.9K | 319,554 | I | ↗ |
| 2025-03-27 | Hohl Benjamin | Officer | M-Exempt | A | Common Stock | 3,250 | 2.48 | 8.1K | 26,250 | D | ↗ |
| 2025-03-24 | Hohl Benjamin | Officer | M-Exempt | D | Stock Option (right to buy) | 1,000 | 2.48 | 2.5K | 131,806 | D | ↗ |
| 2025-03-19 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 12,500 | 20.61 | 257.6K | 1,002,688 | I | ↗ |
| 2025-03-17 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 12,500 | 20.83 | 260.3K | 990,392 | I | ↗ |
| 2025-03-07 | Patel Anish | Officer | S-Sale | D | Common Stock | 6,667 | 21.44 | 142.9K | 323,310 | I | ↗ |
| 2025-03-04 | Hohl Benjamin | Officer | M-Exempt | D | Stock Option (right to buy) | 10,000 | 2.48 | 24.8K | 132,806 | D | ↗ |
| 2025-02-27 | Hohl Benjamin | Officer | S-Sale | D | Common Stock | 3,250 | 20.41 | 66.3K | 13,000 | D | ↗ |
| 2025-02-07 | Patel Anish | Officer | S-Sale | D | Common Stock | 6,667 | 21.93 | 146.2K | 329,977 | I | ↗ |
| 2025-02-06 | Phillips Andrew John | Director | A-Award | A | Stock Option (right to buy) | 20,491 | 22.47 | 460.4K | 20,491 | D | ↗ |
| 2025-02-06 | Patel Anish | Officer | A-Award | A | Stock Option (right to buy) | 171,000 | 22.47 | 3.84M | 171,000 | D | ↗ |
| 2025-02-06 | Lyssikatos Joseph P | Officer | A-Award | A | Stock Option (right to buy) | 171,000 | 22.47 | 3.84M | 171,000 | D | ↗ |
| 2025-02-06 | Kunkel Lori Anne | Director | A-Award | A | Stock Option (right to buy) | 15,368 | 22.47 | 345.3K | 15,368 | D | ↗ |
| 2025-02-06 | Kintz Samuel | Director / Officer | A-Award | A | Stock Option (right to buy) | 490,000 | 22.47 | 11.01M | 490,000 | D | ↗ |
| 2025-02-06 | Hohl Benjamin | Officer | A-Award | A | Stock Option (right to buy) | 171,000 | 22.47 | 3.84M | 171,000 | D | ↗ |
| 2025-02-06 | Heyman Richard A. | Director | A-Award | A | Stock Option (right to buy) | 23,014 | 22.47 | 517.1K | 23,014 | D | ↗ |
| 2025-02-06 | Gupta Rishi | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 20,491 | 22.47 | 460.4K | 20,491 | D | ↗ |
| 2025-02-06 | Derynck Mika K | Director | A-Award | A | Stock Option (right to buy) | 20,491 | 22.47 | 460.4K | 20,491 | D | ↗ |
| 2025-02-06 | Collins Helen Louise | Officer | A-Award | A | Stock Option (right to buy) | 171,000 | 22.47 | 3.84M | 171,000 | D | ↗ |
| 2025-02-06 | Bauer Jake | Director | A-Award | A | Stock Option (right to buy) | 20,491 | 22.47 | 460.4K | 20,491 | D | ↗ |
| 2025-02-06 | Ballal Rahul D. | Director | A-Award | A | Stock Option (right to buy) | 20,491 | 22.47 | 460.4K | 20,491 | D | ↗ |
| 2025-02-05 | Hohl Benjamin | Officer | M-Exempt | A | Common Stock | 1,000 | 2.48 | 2.5K | 14,000 | D | ↗ |
| 2025-01-27 | Hohl Benjamin | Officer | M-Exempt | A | Common Stock | 3,250 | 2.48 | 8.1K | 16,250 | D | ↗ |
| 2025-01-07 | Patel Anish | Officer | S-Sale | D | Common Stock | 1,440 | 24.56 | 35.4K | 0 | D | ↗ |
| 2025-01-03 | Hohl Benjamin | Officer | M-Exempt | D | Stock Option (right to buy) | 1,000 | 2.48 | 2.5K | 150,306 | D | ↗ |
| 2024-12-30 | Hohl Benjamin | Officer | S-Sale | D | Common Stock | 900 | 22.51 | 20.3K | 0 | D | ↗ |
| 2024-12-27 | Hohl Benjamin | Officer | S-Sale | D | Common Stock | 3,350 | 22.15 | 74.2K | 0 | D | ↗ |
| 2024-12-13 | Hohl Benjamin | Officer | M-Exempt | A | Common Stock | 13,000 | 2.48 | 32.2K | 13,000 | D | ↗ |
| 2024-11-27 | Hohl Benjamin | Officer | M-Exempt | D | Stock Option (right to buy) | 5,250 | 2.48 | 13.0K | 168,556 | D | ↗ |
| 2024-10-28 | Hohl Benjamin | Officer | M-Exempt | D | Stock Option (right to buy) | 6,250 | 2.48 | 15.5K | 173,806 | D | ↗ |
| 2024-10-18 | Patel Anish | Officer | S-Sale | D | Common Stock | 716 | 30.00 | 21.5K | 343,311 | I | ↗ |
| 2024-10-18 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 847 | 30.00 | 25.4K | 1,015,188 | I | ↗ |
| 2024-10-18 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 924 | 30.00 | 27.7K | 1,002,892 | I | ↗ |
| 2024-10-18 | Hohl Benjamin | Officer | S-Sale | D | Common Stock | 814 | 30.00 | 24.4K | 0 | D | ↗ |
| 2024-10-18 | Heyman Richard A. | Director | S-Sale | D | Common Stock | 753 | 30.00 | 22.6K | 27,165 | I | ↗ |
| 2024-10-18 | Collins Helen Louise | Officer | S-Sale | D | Common Stock | 816 | 30.00 | 24.5K | 0 | D | ↗ |
| 2024-10-15 | Heyman Richard A. | Director | S-Sale | D | Common Stock | 1,270 | 27.67 | 35.1K | 124,490 | D | ↗ |
| 2024-10-09 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 34,289 | 28.12 | 964.2K | 1,019,624 | I | ↗ |
| 2024-10-09 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 2,830 | 28.53 | 80.7K | 1,003,816 | I | ↗ |
| 2024-10-08 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 100 | 28.51 | 2.9K | 1,053,913 | I | ↗ |
| 2024-10-08 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 100 | 28.51 | 2.9K | 1,020,526 | I | ↗ |
| 2024-10-08 | Ballal Rahul D. | Director | M-Exempt | D | Stock Option (right to buy) | 6,314 | 19.68 | 124.3K | 69,428 | D | ↗ |
| 2024-10-07 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 2,707 | 27.61 | 74.7K | 1,067,180 | I | ↗ |
| 2024-10-07 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 2,730 | 27.50 | 75.1K | 1,033,793 | I | ↗ |
| 2024-10-07 | Hohl Benjamin | Officer | M-Exempt | A | Common Stock | 1,270 | 2.48 | 3.1K | 2,000 | D | ↗ |
| 2024-10-04 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 7,522 | 27.51 | 206.9K | 1,069,887 | I | ↗ |
| 2024-10-04 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 12,206 | 27.51 | 335.8K | 1,036,523 | I | ↗ |
| 2024-10-04 | Hohl Benjamin | Officer | S-Sale | D | Common Stock | 10,218 | 27.51 | 281.1K | 0 | D | ↗ |
| 2024-10-04 | Heyman Richard A. | Director | S-Sale | D | Common Stock | 2,825 | 27.51 | 77.7K | 125,760 | D | ↗ |
| 2024-10-01 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 527 | 27.54 | 14.5K | 1,077,409 | I | ↗ |
| 2024-10-01 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 526 | 27.54 | 14.5K | 1,048,729 | I | ↗ |
| 2024-10-01 | Hohl Benjamin | Officer | M-Exempt | D | Stock Option (right to buy) | 521 | 2.48 | 1.3K | 192,358 | D | ↗ |
| 2024-10-01 | Heyman Richard A. | Director | S-Sale | D | Common Stock | 518 | 27.54 | 14.3K | 128,585 | D | ↗ |
| 2024-09-30 | Hohl Benjamin | Officer | M-Exempt | A | Common Stock | 2,000 | 2.48 | 5.0K | 2,000 | D | ↗ |
| 2024-09-27 | Hohl Benjamin | Officer | M-Exempt | A | Common Stock | 4,250 | 2.48 | 10.5K | 4,250 | D | ↗ |
| 2024-09-16 | Heyman Richard A. | Director | S-Sale | D | Common Stock | 1,270 | 22.41 | 28.5K | 129,103 | — | ↗ |
| 2024-08-29 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 11,950 | 22.48 | 268.7K | 1,077,986 | — | ↗ |
| 2024-08-27 | Hohl Benjamin | Officer | M-Exempt | D | Stock Option (right to buy) | 4,250 | 2.48 | 10.5K | 199,129 | — | ↗ |
| 2024-08-26 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 12,000 | 22.89 | 274.7K | 1,049,255 | — | ↗ |
| 2024-08-15 | Heyman Richard A. | Director | S-Sale | D | Common Stock | 650 | 22.82 | 14.8K | 130,993 | — | ↗ |
| 2024-07-31 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 3,099 | 27.56 | 85.4K | 1,089,936 | — | ↗ |
| 2024-07-31 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 2,270 | 27.56 | 62.6K | 1,061,255 | — | ↗ |
| 2024-07-31 | Hohl Benjamin | Officer | M-Exempt | A | Common Stock | 991 | 2.48 | 2.5K | 991 | — | ↗ |
| 2024-07-31 | Heyman Richard A. | Director | S-Sale | D | Common Stock | 649 | 27.50 | 17.8K | 27,918 | — | ↗ |
| 2024-07-29 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 11,797 | 26.69 | 314.8K | 1,093,238 | — | ↗ |
| 2024-07-29 | Hohl Benjamin | Officer | M-Exempt | D | Stock Option (right to buy) | 5,250 | 2.48 | 13.0K | 204,370 | — | ↗ |
| 2024-07-25 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 8,164 | 25.10 | 204.9K | 1,063,568 | — | ↗ |
| 2024-07-16 | Patel Anish | Officer | S-Sale | D | Common Stock | 1,547 | 25.01 | 38.7K | 344,027 | — | ↗ |
| 2024-07-15 | Patel Anish | Officer | S-Sale | D | Common Stock | 30,978 | 25.05 | 776.0K | 345,574 | — | ↗ |
| 2024-07-15 | Heyman Richard A. | Director | S-Sale | D | Common Stock | 1,270 | 24.80 | 31.5K | 133,345 | — | ↗ |
| 2024-07-12 | Patel Anish | Officer | S-Sale | D | Common Stock | 17,475 | 25.07 | 438.1K | 376,552 | — | ↗ |
| 2024-07-12 | Hohl Benjamin | Officer | M-Exempt | D | Stock Option (right to buy) | 3,000 | 2.48 | 7.4K | 209,620 | — | ↗ |
| 2024-07-01 | Lyssikatos Joseph P | Officer | S-Sale | D | Common Stock | 12,000 | 22.89 | 274.7K | 1,105,035 | — | ↗ |
| 2024-06-27 | Hohl Benjamin | Officer | S-Sale | D | Common Stock | 1,280 | 21.79 | 27.9K | 2,970 | — | ↗ |
| 2024-06-25 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 578 | 22.30 | 12.9K | 1,075,525 | — | ↗ |
| 2024-06-17 | Heyman Richard A. | Director | S-Sale | D | Common Stock | 1,270 | 21.48 | 27.3K | 134,615 | — | ↗ |
| 2024-06-06 | Patel Anish | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 1,133 | 2.48 | 2.8K | 53,342 | — | ↗ |
| 2024-05-29 | Lyssikatos Joseph P | Director / Officer | M-Exempt | D | Stock Option (right to buy) | 12,000 | 1.12 | 13.4K | 206,550 | — | ↗ |
| 2024-05-28 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 6,681 | 22.86 | 152.8K | 5,319 | — | ↗ |
| 2024-05-28 | Hohl Benjamin | Officer | S-Sale | D | Common Stock | 2,334 | 23.42 | 54.7K | 10 | — | ↗ |
| 2024-05-16 | ORBIMED ADVISORS LLC | Director / 10% Owner | S-Sale | D | Common Stock | 1,000,000 | 22.14 | 22.14M | 7,663,349 | — | ↗ |
| 2024-05-16 | Heyman Richard A. | Director | S-Sale | D | Common Stock | 1,270 | 23.74 | 30.1K | 135,885 | — | ↗ |
| 2024-05-16 | Gupta Rishi | Director / 10% Owner | S-Sale | D | Common Stock | 1,000,000 | 22.14 | 22.14M | 7,663,349 | — | ↗ |
| 2024-05-14 | Patel Anish | Officer | S-Sale | D | Common Stock | 1,107 | 25.00 | 27.7K | 0 | — | ↗ |
| 2024-05-09 | Patel Anish | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 260 | 2.48 | 644.80 | 55,582 | — | ↗ |
| 2024-05-06 | Patel Anish | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 4,875 | 2.48 | 12.1K | 55,842 | — | ↗ |
| 2024-05-03 | Hohl Benjamin | Officer | M-Exempt | D | Stock Option (right to buy) | 1,000 | 2.48 | 2.5K | 221,120 | — | ↗ |
| 2024-04-29 | Lyssikatos Joseph P | Director / Officer | S-Sale | D | Common Stock | 1,013 | 18.48 | 18.7K | 0 | — | ↗ |
| 2024-04-29 | Hohl Benjamin | Officer | S-Sale | D | Common Stock | 3,250 | 16.97 | 55.2K | 0 | — | ↗ |
| 2024-04-25 | Kintz Samuel | Director / Officer | M-Exempt | A | Common Stock | 12,000 | 1.12 | 13.4K | 12,000 | — | ↗ |
| 2024-04-15 | Heyman Richard A. | Director | S-Sale | D | Common Stock | 80 | 20.68 | 1.7K | 137,155 | — | ↗ |
| 2024-04-11 | Patel Anish | Officer | S-Sale | D | Common Stock | 17,500 | 25.03 | 438.1K | 0 | — | ↗ |
| 2024-04-11 | Lyssikatos Joseph P | Director / Officer | S-Sale | D | Common Stock | 30,000 | 25.04 | 751.3K | 0 | — | ↗ |
| 2024-04-11 | Kintz Samuel | Director / Officer | S-Sale | D | Common Stock | 47,709 | 25.04 | 1.19M | 0 | — | ↗ |
| 2024-04-11 | Hohl Benjamin | Officer | S-Sale | D | Common Stock | 10,223 | 25.04 | 256.0K | 0 | — | ↗ |
| 2024-04-11 | Heyman Richard A. | Director | S-Sale | D | Common Stock | 5,045 | 25.03 | 126.3K | 138 | — | ↗ |
| 2024-04-11 | Collins Helen Louise | Officer | S-Sale | D | Common Stock | 20,000 | 25.07 | 501.5K | 0 | — | ↗ |
| 2024-04-11 | Ballal Rahul D. | Director | M-Exempt | A | Common Stock | 4,580 | 19.68 | 90.1K | 75,741 | — | ↗ |
| 2024-04-10 | Ballal Rahul D. | Director | S-Sale | D | Common Stock | 13,600 | 21.01 | 285.7K | 22,341 | — | ↗ |
| 2024-04-08 | Patel Anish | Officer | S-Sale | D | Common Stock | 4,331 | 18.50 | 80.1K | 3,141 | — | ↗ |
| 2024-04-08 | Kunkel Lori Anne | Director | A-Award | A | Stock Option (right to buy) | 37,882 | 18.30 | 693.2K | 37,882 | — | ↗ |
| 2024-04-04 | Ballal Rahul D. | Director | M-Exempt | D | Stock Option (right to buy) | 3,485 | 12.60 | 43.9K | 62,420 | — | ↗ |
| 2024-04-01 | Lyssikatos Joseph P | Director / Officer | M-Exempt | D | Stock Option (right to buy) | 12,000 | 1.12 | 13.4K | 260,550 | — | ↗ |
| 2024-04-01 | Ballal Rahul D. | Director | M-Exempt | D | Stock Option (right to buy) | 94 | 12.60 | 1.2K | 65,905 | — | ↗ |
| 2024-03-27 | Hohl Benjamin | Officer | M-Exempt | A | Common Stock | 3,250 | 2.48 | 8.1K | 3,250 | — | ↗ |
| 2024-03-25 | Kintz Samuel | Director / Officer | M-Exempt | D | Stock Option (right to buy) | 12,000 | 1.12 | 13.4K | 260,550 | — | ↗ |
| 2024-03-20 | Ballal Rahul D. | Director | M-Exempt | A | Common Stock | 13,278 | 5.52 | 73.3K | 35,619 | — | ↗ |
| 2024-03-19 | Heyman Richard A. | Director | S-Sale | D | Common Stock | 1,270 | 14.50 | 18.4K | 143,470 | — | ↗ |
| 2024-03-06 | Patel Anish | Officer | S-Sale | D | Common Stock | 4,875 | 15.64 | 76.2K | 7,472 | — | ↗ |
| 2024-02-29 | Lyssikatos Joseph P | Director / Officer | M-Exempt | A | Common Stock | 12,000 | 1.12 | 13.4K | 12,000 | — | ↗ |
| 2024-02-27 | Hohl Benjamin | Officer | M-Exempt | D | Stock Option (right to buy) | 3,250 | 2.48 | 8.1K | 242,620 | — | ↗ |
| 2024-02-15 | Heyman Richard A. | Director | S-Sale | D | Common Stock | 1,270 | 17.42 | 22.1K | 144,740 | — | ↗ |
| 2024-02-14 | 5AM Partners VI, LLC | 10% Owner | S-Sale | D | Common Stock | 688,358 | 14.90 | 10.26M | 3,200,634 | — | ↗ |
| 2024-02-13 | Phillips Andrew John | Director | A-Award | A | Stock Option (right to buy) | 16,835 | 14.85 | 250.0K | 16,835 | — | ↗ |
| 2024-02-13 | Patel Anish | Officer | A-Award | A | Stock Option (right to buy) | 185,000 | 14.85 | 2.75M | 185,000 | — | ↗ |
| 2024-02-13 | Lyssikatos Joseph P | Director / Officer | A-Award | A | Stock Option (right to buy) | 185,000 | 14.85 | 2.75M | 185,000 | — | ↗ |
| 2024-02-13 | Kintz Samuel | Director / Officer | A-Award | A | Stock Option (right to buy) | 410,000 | 14.85 | 6.09M | 410,000 | — | ↗ |
| 2024-02-13 | Hohl Benjamin | Officer | A-Award | A | Stock Option (right to buy) | 185,000 | 14.85 | 2.75M | 185,000 | — | ↗ |
| 2024-02-13 | Heyman Richard A. | Director | A-Award | A | Stock Option (right to buy) | 21,043 | 14.85 | 312.5K | 21,043 | — | ↗ |
| 2024-02-13 | Gupta Rishi | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 16,835 | 14.85 | 250.0K | 16,835 | — | ↗ |
| 2024-02-13 | Derynck Mika K | Director | A-Award | A | Stock Option (right to buy) | 16,835 | 14.85 | 250.0K | 16,835 | — | ↗ |
| 2024-02-13 | Collins Helen Louise | Officer | A-Award | A | Stock Option (right to buy) | 185,000 | 14.85 | 2.75M | 185,000 | — | ↗ |
Executive team
Top executives
Shares Outstanding
60.90M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2023 | Sam Kintz, M.B.A. President and Chief Executive Officer | 561.2K | — | — | 7.41M | 302.5K | 2.7K | 8.28M | 89.54% | ↗ |
| 2 | 2023 | Helen Collins, M.D. Chief Medical Officer | 479.0K | — | — | 3.38M | 204.6K | 2.6K | 4.06M | 83.12% | ↗ |
| 3 | 2023 | Joseph P. Lyssikatos, Ph.D. Chief Scientific Officer | 436.5K | — | — | 3.38M | 193.6K | 2.6K | 4.01M | 84.23% | ↗ |
| 4 | 2023 | Rahul D. Ballal, Ph.D. Former President and Chief Executive Officer | 113.9K | — | — | 499.9K | — | 1.25M | 1.87M | 26.79% | ↗ |
| 5 | 2022 | Rahul D. Ballal, Ph.D. Former President and Chief Executive Officer | 547.9K | 275.0K | 181.3K | 135.3K | — | 10.1K | 1.15M | 27.54% | ↗ |
| 6 | 2022 | Sam Kintz, M.B.A. President and Chief Executive Officer | 400.0K | — | — | 126.8K | 195.0K | 2.0K | 723.8K | 17.52% | ↗ |
| 7 | 2022 | Helen Collins, M.D. Chief Medical Officer | 400.0K | — | — | 87.5K | 156.0K | 2.0K | 645.5K | 13.56% | ↗ |
| 8 | 2022 | Joseph P. Lyssikatos, Ph.D. Chief Scientific Officer | 350.0K | — | — | 27.8K | 156.0K | 2.0K | 535.8K | 5.18% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Samuel S. Kintz | Co-Founder & Head of Pipeline | 956.1K | male |
| Helen Louise Collins | Chief Medical Officer | 726.4K | — |
| Joseph Lyssikatos | Co-Founder & Chief Scientific Officer | 709.4K | — |
| Richard A. Fair | CEO, President & Director | 672.7K | male |
| Benjamin Hohl | Chief Financial Officer & Head of Corporate Development | 667.9K | male |
| Galya D. Blachman | Chief Legal Officer & Head of Business Development | — | — |
| Anish Patel | Co-Founder & Chief Operating Officer | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ELVN
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
